Showing results (431-440 of 490) with videos related to

Sort By:
Pageof 49
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2013
An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosisRebecca A Marsh, Mi-Ok Kim, Chunyan Liu, et al.
The Journal of Pathology. Clinical Research|June 30, 2018
Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancerCamilla Coulson-Gilmer, Matthew P Humphries, Sreekumar Sundara Rajan, et al.
Blood|January 29, 2021
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsisVandana Chaturvedi, Rebecca A Marsh, Adi Zoref-Lorenz, et al.
Haematologica|September 2, 2017
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosisRui Huang, Yoshihiro Hayashi, Xiaomei Yan, et al.
Pediatric Blood & Cancer|October 2, 2018
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosisArun Gurunathan, Alexander A Boucher, Melissa Mark, et al.
Bone Marrow Transplantation|April 11, 2020
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II studyPooja Khandelwal, Tsuyoshi Fukuda, Ashley Teusink-Cross, et al.
Molecular Cell|May 5, 2026
CRL2FEM1B uses heme to recruit BACH1 for degradation and regulate ferroptosis in lung cancerBashir Ahmed, Daniele Salaun, Jack B Jordan, et al.
Critical Care Medicine|October 4, 2021
Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and AdultsMelissa R Hines, Tatiana von Bahr Greenwood, Gernot Beutel, et al.
Breast Cancer Research and Treatment|September 3, 2010
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapyAlastair M Thompson, Andrea Johnson, Philip Quinlan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2016
A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell TransplantationPooja Khandelwal, Chie Emoto, Tsuyoshi Fukuda, et al.
Pageof 49